CDMO Samsung Biologics signs $1.24 billion drug manufacturing deal
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
Drugs
Health
Pharma
Drugs
Health
Pharma
Pfizer pulls out sickle cell therapy from global markets, cites death, snags
Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a.